Fiche publication
Date publication
décembre 2025
Journal
BMC medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Dr KALBACHER Elsa
,
Pr KURTZ Jean-Emmanuel
Tous les auteurs :
Dubot C, Ray-Coquard I, Lequesne J, Pautier P, Renaud T, Selle F, Berton-Rigaud D, Frank S, De La Motte Rouge T, Kalbacher E, Provansal M, Blonz C, Orfeuvre H, Alexandre J, Augereau P, Nadeau C, Kurtz JE, Hanvic B, Fresneau B, Ahmed-Lecheheb D, Christy F, Grellard JM, Clarisse B, Gernier F, Joly F
Lien Pubmed
Résumé
Patients treated for rare ovarian germ cell tumors (GCT) and sex cord stromal tumors (SCST) often experience long-term survival. Treatments include surgery with or without chemotherapy (CT), which can cause late side effects that negatively impact quality of life (QoL). This study assessed long-term QoL among GCT and SCST survivors compared to age-matched healthy women (HW), focusing on patients treated with CT.
Mots clés
Chemotherapy, Germ cell ovarian neoplasms, Long-term effects, Long-term fatigue, Menopause, Quality of life, Sex cord stromal tumors, Sexuality, Survivorship
Référence
BMC Med. 2025 12 12;:
